Contrast-enhanced endoscopic ultrasound versus CT scan in the evaluation of focal pancreatic lesions.

Phase 4

Withdrawn

• Conditions: pancreatic tumor; pancreatic cancer; 10017990

• Registration Number: NL-OMON35110
• Lead Sponsor: Maasstadziekenhuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Not specified
• Target Recruitment: 100

Inclusion Criteria

Individuals with focal pancreatic lesions documented by CT scan

Exclusion Criteria

Patients with unstable coronary artery disease
Known allergy to SonoVue

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Determine the sensitivity of contrast enhanced EUS</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Compare the sensitivity of contrast enhanced EUS with that of CT scan</p><br>